Quick answer: the COSRX Low pH Good Morning Gel Cleanser is a budget stand-in for the La Roche-Posay Effaclar Medicated Gel Cleanser — 64% active overlap sharing Salicylic Acid. It also overlaps with 3 other picks below.
Pricier picks the Low pH Good Morning Gel Cleanser matches
La Roche-Posay
64%
Active overlap
Pricier pickSalicylic Acid
Why it holds up: shares the same hero active — Salicylic Acid — which is what drives results here.
Full ingredient analysis →See them side by side →CeraVe
64%
Active overlap
Pricier pickSalicylic Acid
Why it holds up: shares the same hero active — Salicylic Acid — which is what drives results here.
Full ingredient analysis →See them side by side →Cetaphil
50%
Active overlap
Pricier pickSalicylic AcidTea Tree OilAllantoin
Why it holds up: shares the same hero actives — Salicylic Acid, Tea Tree Oil, Allantoin — which is what drives results here.
Full ingredient analysis →See them side by side →Bioderma
50%
Active overlap
Pricier pickSalicylic AcidTea Tree OilAllantoin
Why it holds up: shares the same hero actives — Salicylic Acid, Tea Tree Oil, Allantoin — which is what drives results here.
Full ingredient analysis →See them side by side →Every match above mirrors an existing dupe page verbatim — re-derived from the 4 comparisons where the Low pH Good Morning Gel Cleanser appears as an alternative. No invented data.
Common questions
Is the COSRX Low pH Good Morning Gel Cleanser a real dupe?
It overlaps on hero actives with 4 same-category products in our catalogue — most closely the La Roche-Posay Effaclar Medicated Gel Cleanser at 64% active overlap. "Dupe" here means shared active ingredients, not an identical formula.
Does a higher overlap mean it is better?
No — overlap only measures shared hero actives. Base, supporting actives, texture and price still differ, so use the side-by-side compare for the full picture.
Go deeper
Low pH Good Morning Gel Cleanser
Full ingredient breakdown for this product.
Open the analysis →Educational information only — not medical advice. Overlap reflects shared hero actives, not clinical equivalence.